CBD Life Sciences (CBD Life Sciences) EV-to-EBITDA : -11.43 (As of May. 17, 2024)

CBD Life Sciences EV-to-EBITDA Chart

CBD Life Sciences Quarterly Data
	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15
EV-to-EBITDA	Get a 7-Day Free Trial											-4.24	-2.46	-3.01	-	-21.79

Competitive Comparison of CBD Life Sciences's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, CBD Life Sciences's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CBD Life Sciences's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CBD Life Sciences's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where CBD Life Sciences's EV-to-EBITDA falls into.

CBD Life Sciences EV-to-EBITDA Calculation

CBD Life Sciences's EV-to-EBITDA for today is calculated as:

CBD Life Sciences's current Enterprise Value is $0.95 Mil.
CBD Life Sciences's EBITDA for the trailing twelve months (TTM) ended in Sep. 2015 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.08 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CBD Life Sciences  (OTCPK:CBDLD) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

CBD Life Sciences's PE Ratio for today is calculated as:

CBD Life Sciences's share price for today is $0.00599.
CBD Life Sciences's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2015 adds up the quarterly data reported by the company within the most recent 12 months, which was $-11746.040.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

CBD Life Sciences EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of CBD Life Sciences's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

CBD Life Sciences (CBD Life Sciences) Business Description